Skip to main content

Unbiased. Straight Facts.TM

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

The U.S. Food and Drug Administration on Thursday granted full approval to Pfizer's (PFE.N) oral antiviral COVID-19 treatment Paxlovid, clearing the way for the drugmaker to sell it at market rates once U.S. government supplies dwindle.

Media Miss by the Right

See who else is reporting on this story and which side of the political spectrum they lean.

73 other sources covering this story

Total News Sources


Leaning Left




Leaning Right


Last Updated

4 months ago

Bias Distribution

Left 21%

Center 75%

Right 5%

Click to see headlines

Far Left






Far Right


Bias Distribution Powered by Ground NewsTM

By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.